Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term Treatment

被引：0
作者：
April Armstrong
Andrew Blauvelt
Eric L. Simpson
Catherine H. Smith
Pedro Herranz
Yoko Kataoka
Seong Jun Seo
Silvia M. Ferrucci
Jingdong Chao
Zhen Chen
Ana B. Rossi
Brad Shumel
Paul Tomondy
机构：
[1] University of Southern California,Keck School of Medicine
[2] Oregon Medical Research Center,Department of Dermatology
[3] Oregon Health and Science University,undefined
[4] St. John’s Institute of Dermatology,undefined
[5] La Paz University Hospital,undefined
[6] Osaka Habikino Medical Center,undefined
[7] Chung-Ang University Hospital,undefined
[8] Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico of Milan,undefined
[9] Regeneron Pharmaceuticals,undefined
[10] Inc.,undefined
[11] Sanofi Genzyme,undefined
[12] pvaluecomm,undefined
来源：
Dermatology and Therapy | 2022年 / 12卷
关键词：
Atopic dermatitis; Dupilumab; Efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：195 / 202
页数：7
相关论文
共 35 条
  • [11] Gadkari A(2020)Efficacy and safety of multiple dupilumab dose regimens after initial successful treatment in patients with atopic dermatitis: a randomized clinical trial JAMA Dermatol 156 131-undefined
  • [12] Gandhi NA(undefined)undefined undefined undefined undefined-undefined
  • [13] Pirozzi G(undefined)undefined undefined undefined undefined-undefined
  • [14] Graham NMH(undefined)undefined undefined undefined undefined-undefined
  • [15] Le Floc'h A(undefined)undefined undefined undefined undefined-undefined
  • [16] Allinne J(undefined)undefined undefined undefined undefined-undefined
  • [17] Nagashima K(undefined)undefined undefined undefined undefined-undefined
  • [18] de Bruin-Weller M(undefined)undefined undefined undefined undefined-undefined
  • [19] Thaci D(undefined)undefined undefined undefined undefined-undefined
  • [20] Smith CH(undefined)undefined undefined undefined undefined-undefined
1234